Event
Specialty Treatments for Resistant Obsessive Compulsive Disorder throughout the Life Span
Panel: Alexa Bagnell, MD, Associate Chief, Child and Adolescent Psychiatry IWK Health Centre, Maritime Psychiatry, and Associate Professor, Dalhousie University; Sandra L Mendlowitz, PhD, Anxiety Disorders Program, SickKids Hospital, and Assistant Professor, University of Toronto; Peggy Richter, MD, Director, Clinic for OCD and Related Disorders, Sunnybrook Health Sciences Centre, and Associate Professor, University of Toronto; Ingrid Sochting, PhD; Chief Psychologist, Richmond Mental Health Services, and Clinical Assistant Professor, University of British Columbia; Noam Soreni, MD, Pediatric OCD Consultation Team, Anxiety Treatment and Research Center, and Associate Professor, McMaster University; and Debbie Sookman, PhD., Director, OCD Clinic, Department of Psychology, McGill University Health Centre, and Associate Professor, McGill University (Chair).
Abstract: Obsessive Compulsive Disorder (OCD) is the fourth most common mental disorder and among the ten leading causes of medical disability world-wide. The members of this panel who are engaged in leadership roles on the Affiliate Educational Outreach Program and/or the Accreditation Task Force of The Canadian Institute for Obsessive Compulsive Disorders (CIOCD, www.ciocd.ca), will address various aspects of resistance to treatment in OCD. The presenters will discuss specialty treatments for OCD throughout the life span and CIOCD mandates (Debbie Sookman, PhD), review current research on cognitive behavior therapy (CBT) for pediatric OCD (Sandra Mendlowitz, PhD), discuss biological and clinical factors associated with higher rates of non-response in childhood onset OCD (Noam Soreni, MD), present the clinical and research work of the first specialty OCD pediatric team developed to service the Maritimes (Alexa Bagnell, MD), present and illustrate group-based CBT interventions for OCD with adolescents (Ingrid Sochting, PhD), and give an overview of OCD related disorders proposed in DSM-5 (Peggy Richter, MD). Discussions among panelists and the audience will follow the brief presentations.
